Beta Adrenoceptor Ligands for the Treatment of Group 3 Pulmonary Hypertension and Cor Pulmonale: A Novel Therapeutic Target?

被引：0
|
作者：
Wang, W. [1 ]
Wilson, C. [1 ]
Collum, S. [1 ]
Bi, W. [1 ]
Ko, J. [1 ]
Rajagopal, K. [2 ]
Karmouty-Quintana, H. [1 ]
机构：
[1] UTHlth McGovern Med Sch, Biochem & Mol Biol, Houston, TX USA
[2] UTHealth, Sch Med, Dept Internal Med, Houston, TX USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2020年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
400
引用
收藏
页码：S169 / S169
页数：1
相关论文
共 50 条
  • [31] ADGRG6/GPR126 as a Novel Therapeutic Target in Pulmonary Arterial Hypertension
    Muthusamy, Abinaya
    Gorr, Matthew W.
    Chinn, Amy M.
    Insel, Paul A.
    FASEB JOURNAL, 2018, 32 (01):
  • [32] RETRACTED: CD248 as a novel therapeutic target in pulmonary arterial hypertension (Retracted Article)
    Xu, Tao
    Shao, Lei
    Wang, Aimei
    Liang, Rui
    Lin, Yuhan
    Wang, Guan
    Zhao, Yan
    Hu, Jing
    Liu, Shuangyue
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (05):
  • [33] PRIMARY PULMONARY VASCULAR DISEASE WITH COR PULMONALE - REPORT OF 3 CASES IN CHILDREN, ONE WITH CONGENITAL HYPERTENSION AND 2 SIBLINGS WITH ALLERGIC VASCULITIS AND DISORDERS OF SKELETAL EPIPHYSES
    BARNARD, PJ
    DAVEL, JGA
    AMA JOURNAL OF DISEASES OF CHILDREN, 1956, 92 (02): : 115 - 125
  • [34] ENDOTHELIAL KRUPPEL-LIKE FACTOR 15: A NOVEL TARGET FOR THE TREATMENT OF PULMONARY HYPERTENSION
    Pandey, Deepesh
    Tori, Daijiro
    Nomura, Yohei
    Berkowitz, Dan
    Romer, Lewis
    JOURNAL OF HYPERTENSION, 2016, 34 : E206 - E207
  • [35] Improvement after Bariatric Surgery in Chronic Thromboembolic Pulmonary Hypertension: A Novel Treatment Target
    Vaidy, Anika
    Forfia, Paul
    Vaidya, Anjali
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S121 - S121
  • [36] Improvement after bariatric surgery in chronic thromboembolic pulmonary hypertension: a novel treatment target
    Vaidy, Anika
    Forfia, Paul
    Mazurek, Jeremy
    Vaidya, Anjali
    BMJ CASE REPORTS, 2021, 14 (03)
  • [37] Challenges Associated With Therapeutic Targeting Of Stat3 For The Treatment Of Pulmonary Hypertension
    El Kasmi, K. C.
    Riddle, S. R.
    Pugliese, S.
    Frid, M. G.
    Li, M.
    Anderson, A.
    Sokol, R.
    Stenmark, K. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [38] Integrin α5β1 represents a novel therapeutic target to improve vascular remodeling in pulmonary arterial hypertension
    Lemay, Sarah-Eve
    Montesinos, Monica
    Grobs, Yann
    Yokokawa, Tetsuro
    Shimauchi, Tsukasa
    Romanet, Charlotte
    Sauvaget, Melanie
    Bonnet, Sandra Breuils
    Bourgeois, Alice
    Theberge, Charlie
    Martineau, Sandra
    Lippa, Blaise
    Goodwin, Bryan
    Lin, Albert
    Wang, Hua
    Dowling, James
    Lu, Min
    Qiao, Qi
    McTeague, T. Andrew
    Moy, Terence I.
    Potus, Francois
    Provencher, Steeve
    Boucherat, Olivier
    Bonnet, Sebastien
    CIRCULATION, 2024, 150
  • [39] Two Small Electrophilic Ligands Of Pparγ Inhibit Tissue Transglutaminase 2, A Novel Therapeutic Target For Pulmonary Fibrosis
    Kulkarni, A. A.
    Olsen, K.
    Epa, A. P.
    Kottmann, R. M.
    Thatcher, T. H.
    Phipps, R. P.
    Sime, P. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [40] Heterogeneity in the Treatment of Group 3 Pulmonary Hypertension: Insights from a National Survey
    Thomas, C.
    Manrique, R. Jesus Bernardo
    Anderson, R. J.
    Glinskii, V.
    Sung, Y. K.
    Kudelko, K.
    Zamanian, R. T.
    Raj, R.
    Perez, V. De Jesus
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345